Connect
← Return to (MAC/MAI) Mycobacterium Avium Complex Pulmonary Disease: Join us
Discussion
(MAC/MAI) Mycobacterium Avium Complex Pulmonary Disease: Join us
MAC & Bronchiectasis | Last Active: Nov 21 5:21pm | Replies (9354)Comment receiving replies
Good information in my cystic fibrosis newsletter that applies to infectious disease patients also. It interferes with the formation of biofilms which protects the bacteria which forms in our lungs when infected. https://cysticfibrosisnewstoday.com/2020/06/01/pravibismane-granted-fda-orphan-drug-designation-for-cf-lung-infections/
Be well~ Linda Martin
Replies to "Good information in my cystic fibrosis newsletter that applies to infectious disease patients also. It interferes..."
Connect
@lindam272 Thanks! I did some searching. Microbion suggests it will help those with MAC, as well: "In addition to CF-related lung infection, there are multiple lower respiratory tract infections and conditions where the presence of microbial pathogens and their associated biofilm contribute to lung function decline. Infectious pathogens such as Pseudomonas spp., Staphylococcus spp., Streptococcus spp., Mycobacterium spp., or Haemophilus spp. may contribute to lung diseases such as non-CF bronchiectasis, bronchitis, community- or ventilator-associated pneumonia, non-tuberculous mycobacterium infection, etc., that are expected to benefit from an inhaled application of pravibismane or other Microbion compounds." https://microbioncorp.com/pipeline/respiratory